TCT-436 Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 6-Month Results from the DESolve PMCF Study

Holger Nef,Karl Eugen Hauptmann,Azeem Latib,Lynn Morrison,Sara Toyloy,Lynn Vandertie,Antonio Colombo

Journal of the American College of Cardiology（2015）

引用 2|浏览6

暂无评分

摘要

Bioresorbable scaffolds are an equivalent alternative to metallic drug-eluting stents for the treatment of coronary artery lesions, but experience with other than Everolimus-eluting PLLA-based scaffolds is limited. A post marketing clinical follow-up study was conducted evaluating the continued

查看译文

关键词

Drug-Eluting Stents,Coronary Stents

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要